adenosine monophosphate has been researched along with rolipram in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fredholm, BB; Li, YO | 1 |
| Boyle, D; Eigler, A; Endres, S; Erhardt, S; Firestein, GS; Hartmann, G; Matschke, V | 1 |
| Bartlett, A; Bobechko, B; Gorseth, E; Gresser, MJ; Huang, Z; Laliberté, F; Lario, P; Liu, S; Van Hamme, J | 1 |
| Anam, EM; Blázquez, MA; Cerdá-Nicolás, M; Cortijo, J; Estellés, R; Issekutz, AC; Ivorra, MD; López-Martín, J; Martínez-Losa, M; Milian, L; Morcillo, EJ; O'Connor, JE; Sanz, MJ | 1 |
| Barnes, PJ; Cambridge, LM; Catley, MC; Giembycz, MA; Lum, H; Meja, KK; Newton, R | 1 |
| Lambert, MH; Luther, MA; Nolte, RT; Rocque, WJ; Vanderwall, DE; Xu, RX | 1 |
| Chen, C; Hu, X; Jiang, H; Liao, F; Liu, M; Long, G; Pu, J; Wu, J; Xie, Y; Yang, X; Yuan, Y | 1 |
| Baeeri, M; Dastgheib, M; Gholami, M; Hosseini, A; Karimi, MY; Shetab-Boushehri, SV | 1 |
8 other study(ies) available for adenosine monophosphate and rolipram
| Article | Year |
|---|---|
Adenosine analogues stimulate cyclic AMP formation in rabbit cerebral microvessels via adenosine A2-receptors.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cats; Cerebral Cortex; Colforsin; Cyclic AMP; Diterpenes; Microcirculation; Phenylisopropyladenosine; Pyrrolidinones; Rabbits; Receptors, Cell Surface; Receptors, Purinergic; Rolipram | 1985 |
Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
Topics: Adenosine; Adenosine Kinase; Adenosine Monophosphate; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Depression, Chemical; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Interleukin-10; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Ribonucleosides; Rolipram; Second Messenger Systems; Thionucleotides; Tumor Necrosis Factor-alpha | 2000 |
Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Monophosphate; Apoenzymes; Binding Sites; Binding, Competitive; Cations, Divalent; Cobalt; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Kinetics; Ligands; Magnesium; Manganese; Models, Chemical; Peptide Fragments; Phosphodiesterase Inhibitors; Recombinant Fusion Proteins; Rolipram; Stereoisomerism | 2001 |
Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
Topics: Adenosine Monophosphate; Alkaloids; Animals; Calcium; Cell Communication; Cell Line; Colforsin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Leukocyte Rolling; Leukocytes; Male; Microscopy, Video; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenanthrenes; Plant Extracts; Platelet Activating Factor; Protein Binding; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rolipram | 2003 |
Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89.
Topics: Activating Transcription Factor 1; Adaptor Proteins, Signal Transducing; Adenosine Monophosphate; Adenoviridae; Albuterol; Animals; Arachidonic Acid; Carrier Proteins; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Drug Interactions; Epithelial Cells; Gene Expression Regulation; Gene Transfer Techniques; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intracellular Signaling Peptides and Proteins; Isoquinolines; Phosphorylation; Rabbits; Rolipram; Sulfonamides; Transcription Factors; Tritium | 2004 |
Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Monophosphate; Adenosine Triphosphate; Amino Acid Sequence; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; In Vitro Techniques; Macromolecular Substances; Models, Molecular; Molecular Sequence Data; Mutation; Phosphodiesterase Inhibitors; Protein Structure, Tertiary; Rolipram; Sequence Homology, Amino Acid; Static Electricity | 2004 |
Microplate-based method to screen inhibitors of isozymes of cyclic nucleotide phosphodiesterase fused to SUMO.
Topics: Adenosine Monophosphate; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Assays; Escherichia coli; Gene Expression; High-Throughput Screening Assays; Humans; Isoenzymes; Kinetics; Papaverine; Phosphates; Phosphodiesterase 4 Inhibitors; Recombinant Fusion Proteins; Rolipram; Rosaniline Dyes; Small Ubiquitin-Related Modifier Proteins | 2014 |
Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons.
Topics: Adenosine Monophosphate; Animals; Biomarkers; Cyclooxygenase 2; Diabetic Neuropathies; Ganglia, Spinal; Neurons; NF-kappa B; Oxidative Stress; Pentoxifylline; Phosphodiesterase 4 Inhibitors; Rats; Reactive Oxygen Species; Rolipram; Sulfhydryl Compounds; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |